PeerJ · 2026
Oil-in-water nanoemulsion-based ethyl lauroyl arginate nanoparticles exhibit potent antibacterial and antibiofilm activity against oral pathogens.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wongkaewkhiaw Saharut, Pairojana Tanita, Chansiri Sirirat, Tsao Stephany, Panmekiate Soontra, Vipismakul Vichittra, Worapamorn Wilairat, Srisukho Kanokraj, Tangratchatakul Lalita, Timpawat Siriporn, Jumjitvi Panitan, Rimrang Pisut, Nittayasut Naiyaphat, Yata Teerapong, Bikker Floris J
Аннотация
BACKGROUND: Dental biofilm is a key etiological factor in oral diseases such as dental caries and periodontal disease, and has also been linked to systemic health complications. In this study, ethyl lauroyl arginate nanoparticles (ELANPs) were formulated using an oil-in-water nanoemulsion system to investigate their antibiofilm capacity and cellular cytotoxicity in vitro.
METHODS: The morphology of ELANPs was examined using transmission electron microscopy (TEM). Particle size, polydispersity index (PDI), and zeta potential were evaluated to assess nanoparticle stability over time. Biofilm matrix reduction was analyzed using confocal laser scanning microscopy (CLSM), and cytotoxicity was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
RESULTS: ELANPs displayed a spherical morphology with an average diameter of 84.3 ± 2.6 nm. The zeta potential was 46.7 ± 4.6 mV, and the PDI was 0.18 ± 0.01, indicating good colloidal uniformity and stable nanosuspensions. Slight changes in physicochemical properties were observed at days 14 and 30, and overall stability was maintained. ELANPs significantly reduced the biofilm matrix across all tested oral pathogens while maintaining low cytotoxicity toward normal human gingival fibroblasts.
CONCLUSION: The findings indicate that ELANPs are physicochemically stable, capable of inhibiting oral biofilm formation, and exhibit minimal cytotoxicity, supporting their potential as a safe and effective oral healthcare agent.
METHODS: The morphology of ELANPs was examined using transmission electron microscopy (TEM). Particle size, polydispersity index (PDI), and zeta potential were evaluated to assess nanoparticle stability over time. Biofilm matrix reduction was analyzed using confocal laser scanning microscopy (CLSM), and cytotoxicity was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
RESULTS: ELANPs displayed a spherical morphology with an average diameter of 84.3 ± 2.6 nm. The zeta potential was 46.7 ± 4.6 mV, and the PDI was 0.18 ± 0.01, indicating good colloidal uniformity and stable nanosuspensions. Slight changes in physicochemical properties were observed at days 14 and 30, and overall stability was maintained. ELANPs significantly reduced the biofilm matrix across all tested oral pathogens while maintaining low cytotoxicity toward normal human gingival fibroblasts.
CONCLUSION: The findings indicate that ELANPs are physicochemically stable, capable of inhibiting oral biofilm formation, and exhibit minimal cytotoxicity, supporting their potential as a safe and effective oral healthcare agent.